Tivantinib (ARQ 197) vs Placebo in Patients (Pts) with Hepatocellular Carcinoma (HCC) Who Failed One Systemic Therapy: Results of a Randomized Controlled Phase 2 Trial (RCT)

Friday, June 1, 2012   Posters and Presentations

Questions or Concerns?

Please feel free to contact by one of the methods below

Online Form   Call (781) 994-0300